MERUS LABS INTERNATIONAL INC T.MSL

BREXIT

[oilflow1]

Anyone know how the Pound drop affects MSL?  Is it a wash as all costs and revenues are in the same currency or is it a negative as the trading would suggest?

[campst]

a good chunk of their business is in europe, which is one of the reasons I bought it.  Since they report by product and the fact that this is a roll-up make it difficult to identify results by region.  I guesstimate between 40% and 50% - just a guess remember.  And need to keep in mind that while revenue may drop, so do the european costs. Although relative declines in euro and

[Kensin1953]

Well you know more then most it appears. Too bad I stayed up late to see if Cameron was going to CEXIT and slept in and missed the $1.47  Funny how it hit the 52 week low and bounced. Not $1.46 or $1.48 but dead on $1.47  You have to love computer controlled investing.  The catalyst for this company will be sales , distribution arrangements, a new proprietory drug , another key

[lscfa]

Revenues in euros, most costs in euros once plant transfer at end of year, financing is in euros, euro vs. CAD is steady....conclusion = little effect.....

[lscfa]

Also, "In  connection  with  its  European  operations,  the  Company  uses  foreign  currency  contracts  in order  to  partially  hedge  the  risk  associated  with  its  Euro  currency  source  revenue."........

[campst]

Isfca.  Do you have a guess on revenue split NA vs. europe?

[lscfa]

.....note 15 of financials says: 15. Segment information The Company operates in a single reportable segment focused on acquiring, in-licensing, marketing and distributing pharmaceutical products in Canada and internationally.  The Company carries out business principally in Canada and Europe.   Revenues by geographic region are detailed as follows: Three months ended March 31 2016

[oilflow1]

Thank you campst and Isfca.  So BREXIT shoudn't really be a huge issue, maybe that's why the bounce back from the low.